Navigation Links
Potential new drug for some patients with treatment-resistant lung cancer
Date:10/20/2013

ring lung tumors with resistance mutations. AZD9291 showed substantial tumor shrinkage in both groups of mice after 14 days of treatment. After 40 days, the researchers found no visible tumors in these mice, and this effect was sustained for more than 100 days. They also observed similar tumor shrinkage in mice that were genetically modified to develop tumors bearing both the activating and resistance mutations.

When the investigators analyzed blood samples collected from the treated mice, they identified a breakdown product of the parent compound AZD9291, which they called AZ5104, circulating in blood in addition to AZD9291. They then found that AZ5104 is also a potent inhibitor of activating and resistance EGFR mutations, and speculated that this may contribute to the efficacy seen after dosing with AZD9291.

Using data from blood analyses of mice, the researchers then developed a mathematical model to evaluate the dynamics of conversion of AZD9291 to AZ5104 and cumulative tumor-inhibitory effects. These experiments helped them determine the potentially effective doses of AZD9291 for patients with NSCLC harboring both activating and resistance EGFR mutations.

"Findings from preclinical studies have recently been translated to the clinic, where the drug has already demonstrated tumor shrinkage in patients and has been well tolerated, with low rates of side effects," said Galbraith. "The degree of response to treatment with AZD9291 in such a short period of time is very exciting. This new drug has the potential to provide new treatment options for patients in this setting."


'/>"/>

Contact: Lauren Riley
lauren.riley@aacr.org
215-446-7155
American Association for Cancer Research
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Study identifies potential treatment for lethal childhood leukemia
2. McMaster researchers find potential for new uses of old drug
3. Army researcher develops potential vaccine carrier
4. UNC study shows potential to revive abandoned cancer drug by nanoparticle drug delivery
5. New study of NIH funding allocations suggests potential efficiency gains
6. A closer look at PARP-1 reveals potential new drug targets
7. Hybrid vaccine demonstrates potential to prevent breast cancer recurrence
8. VCU Massey Cancer Center sees potential in novel leukemia treatment
9. Misuse of over-the-counter pain medication is potential health threat
10. Mutations in JAK3 gene identified in subtype of lymphoma provide potential drug target
11. Bioinformatics experts at the CNIO explore additional coding potential hidden in the human genome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... ... 04, 2015 , ... The Schmidt National Law Group filed an Essure® lawsuit ... Schmidt National Law Group, a leading firm in mass-tort litigation, has filed a lawsuit ... Essure, Inc., and other Bayer affiliates for injuries alleged to have been caused by ...
(Date:9/4/2015)... , ... September 04, 2015 , ... After wearing the ... desperate need of new apparel. In an effort to assist the team, the Jones ... launched a charity drive to raise funds for the new uniforms. , As is ...
(Date:9/4/2015)... ... September 04, 2015 , ... Keeping mold top of mind ... home is quite common. Mold can grow anywhere - on carpet, clothing, food, paper, ... for excessive moisture and water in the home is key to preventing mold growth, ...
(Date:9/4/2015)... ... ... are looking for a quick and convenient way to produce a hot remedy for colds. ... a quick and simple way to brew a hot cup of cold remedy when desired. ... they enhance comfort and health. The invention features a novel design that is lightweight, compact ...
(Date:9/4/2015)... ... 2015 , ... Having access to a doctor can sometimes be a challenge ... unnecessary emergency room visits which affects hospitals’ abilities to provide quality service to those ... solution to alleviate this problem has recently presented itself, the new telemedicine platform and ...
Breaking Medicine News(10 mins):Health News:Schmidt National Law Group Files First Bayer Essure® Lawsuit in California 2Health News:The Jones Agency Serves Up a Charity Drive to Fund New Uniforms for the Sprayberry High School Girls Volleyball Team 2Health News:The Jones Agency Serves Up a Charity Drive to Fund New Uniforms for the Sprayberry High School Girls Volleyball Team 3Health News:September is Mold Awareness Month 2Health News:September is Mold Awareness Month 3Health News:September is Mold Awareness Month 4Health News:Redesigned Packaging for Powdered Medicinal Mix Invented by InventHelp® Client (CBA-2637) 2Health News:Telemedicine Platform DocChat Announces Launch Offering a Way for Patients to Consult Doctors and Receive Prescriptions 24/7 2Health News:Telemedicine Platform DocChat Announces Launch Offering a Way for Patients to Consult Doctors and Receive Prescriptions 24/7 3
... winter diaper rash and predicts a moderate to severe 2008/2009 ... 2 /PRNewswire/ -- For the parents ... mean cute little red outfits, cute little red button noses, ... about their baby,s skin health until sunscreen season comes around ...
... Don,t let snow shoveling ruin your winter wonderland , ... shoveling tends to be an unpleasant task -- this mundane seasonal ... to the back, shoulder muscles if shovelers do not take the ... (AAOS) ( www.aaos.org ) has recommendations to help you stay ...
... Expand to 70 Cities and Regions by 2010 , ... first investment of a new $44 million initiative, the Robert Wood ... nine communities across the country that will serve as leading sites ... epidemic. , , Healthy Kids, ...
... the December 1, 2008, issue of Clinical Cancer ... Cancer Research, show lapatinib benefits women with HER2-positive breast ... who express EGRF alone derive no incremental benefit. In ... as much as 10 percent prevents some people from ...
... DIEGO, Dec. 2 Stroller Strides , the country,s ... announced that Pampers , a leader in baby ... premier sponsor for 2009. , , The ... toddlers and moms. , , "We are ...
... Efficiency by Automating Access Management for 8,000 Users ... Mass., Dec. 2 Courion(R) Corporation , leaders ... Senior Living, the nation,s largest owner and operator of ... to deliver and manage secure access to enterprise applications ...
Cached Medicine News:Health News:Photos: Heads Up, Parents: Get to the Bottom of Winter Diaper Rash 2Health News:Photos: Heads Up, Parents: Get to the Bottom of Winter Diaper Rash 3Health News:Photos: Heads Up, Parents: Get to the Bottom of Winter Diaper Rash 4Health News:Let it Snow, Let it Snow, Let it Snow 2Health News:Let it Snow, Let it Snow, Let it Snow 3Health News:Let it Snow, Let it Snow, Let it Snow 4Health News:Robert Wood Johnson Foundation Awards Grants to Nine Communities In Launch of $44 Million National Program to Reverse Childhood Obesity 2Health News:Robert Wood Johnson Foundation Awards Grants to Nine Communities In Launch of $44 Million National Program to Reverse Childhood Obesity 3Health News:Robert Wood Johnson Foundation Awards Grants to Nine Communities In Launch of $44 Million National Program to Reverse Childhood Obesity 4Health News:HER2 levels may aid in treatment selection for metastatic breast cancer 2Health News:Stroller Strides(R) Signs Pampers(R) as Premier Sponsor for 2009 2Health News:Courion Helps Reduce Costs at Nation's Largest Operator of Senior Living Communities 2Health News:Courion Helps Reduce Costs at Nation's Largest Operator of Senior Living Communities 3
(Date:9/4/2015)... plc (NYSE: AGN ) a leading global pharmaceutical company, ... of Allergan, will provide an overview and update of the ... in New York, NY . ... will take place on Thursday, September 17, 2015 at 10:35 ... East 42nd Street, New York, NY ...
(Date:9/4/2015)... , Sept. 4, 2015  IGI Laboratories, Inc. (NYSE ... based specialty generic pharmaceutical company, today announced it has ... the U.S. Food and Drug Administration (FDA) of 2015, ... now pending at the FDA to twenty-nine. ... Company, commented, "We believe our current pipeline of twenty-nine ...
(Date:9/4/2015)... Sep. 04, 2015 ... the addition of the "Veterinary Pharmaceutical Submissions ... 2015)" conference to their offering. ... all of the constituent parts of the application ... for which a marketing authorisation is sought in ...
Breaking Medicine Technology:Allergan to Present at Morgan Stanley Global Healthcare Conference 2015 2Allergan to Present at Morgan Stanley Global Healthcare Conference 2015 3IGI Laboratories, Inc. Announces Seventh ANDA Submission Of 2015 2Veterinary Pharmaceutical Submissions in the EU: Two day Course - London, UK - December 7-8, 2015 2
... RDEA806, Demonstrated No Reproductive Toxicity in ... Preclinical Study -, - RDEA427 ... with Potential ... Ardea Biosciences, Inc.,(Nasdaq: RDEA ) today announced preclinical data on its ...
... of Inhaled ... Treprostinil, ... ) and its wholly-owned subsidiary,Lung Rx, Inc. today announced that data ... treprostinil,were reported at the American Thoracic Society (ATS) meeting in Toronto,Ontario. ...
Cached Medicine Technology:Ardea Announces Progress with HIV Non-Nucleoside Reverse Transcriptase Inhibitor Program 2Ardea Announces Progress with HIV Non-Nucleoside Reverse Transcriptase Inhibitor Program 3Ardea Announces Progress with HIV Non-Nucleoside Reverse Transcriptase Inhibitor Program 4Treprostinil Data Presented at American Thoracic Society Conference Demonstrates Significant Clinical Progress in All Four Routes of Administration 2Treprostinil Data Presented at American Thoracic Society Conference Demonstrates Significant Clinical Progress in All Four Routes of Administration 3Treprostinil Data Presented at American Thoracic Society Conference Demonstrates Significant Clinical Progress in All Four Routes of Administration 4Treprostinil Data Presented at American Thoracic Society Conference Demonstrates Significant Clinical Progress in All Four Routes of Administration 5Treprostinil Data Presented at American Thoracic Society Conference Demonstrates Significant Clinical Progress in All Four Routes of Administration 6
... Sun Med TruFlow™ Oxygen flowmeter with a ... warranty covering calibration and manufacturing defects. A ... meet most needs. Also available with all ... power take-off and double unit configurations. Our ...
... TruFlow™ Oxygen flowmeter with a Lexan®inner calibrated ... calibration and manufacturing defects. A wide range ... needs. Also available with all popular inlet ... and double unit configurations. Our extra large ...
... flowmeter with a Lexan®inner calibrated flow tube ... manufacturing defects. A wide range of configurations ... available with all popular inlet connections, a ... unit configurations. Our extra large knob coupled ...
... adults, the entire series of time-tested Timeter® ... the needs of care providers and patients ... accuracy. You can see it in the ... performance, year after year. Every Timeter® Classic ...
Medicine Products: